Literature DB >> 2799907

Cholestasis in the rat by means of intravenous administration of cyclosporine vehicle, Cremophor EL.

I D Roman1, M J Monte, A Esteller, R Jimenez.   

Abstract

The effect of cyclosporine vehicle, Cremophor EL, on bile flow and biliary bile acids and bilirubin output was studied in anesthetized male Wistar rats. Intravenous administration of Cremophor EL or castor oil as a single bolus reduced bile flow and the biliary output of bile acids and bilirubin. The Cremophor EL-induced cholestasis was an immediate and reversible phenomenon, since at 30-35 min after drug injection all parameters evaluated had returned to control values. A slight increase in serum bilirubin concentrations was observed. Our data indicate that the observed cholestasis is related to a reduction in both bile acid-dependent and bile acid-independent bile flow, probably due to a transitory hepatotoxic effect of Cremophor EL. We conclude that the clinically used vehicle for i.v. administration of cyclosporine, Cremophor EL, has adverse effects on hepatobiliary physiology in the rat and suggest that an alternative vehicle should be used.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2799907     DOI: 10.1097/00007890-198910000-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Role of formulation vehicles in taxane pharmacology.

Authors:  L van Zuylen; J Verweij; A Sparreboom
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

2.  Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats.

Authors:  S Yasumiba; S Tazuma; H Ochi; K Chayama; G Kajiyama
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

3.  Effect of dietary lipid (soybean lecithin and triacylglycerol) on hepatic F-actin microfilaments in cyclosporine A-treated rats: image analysis by confocal laser scanning microscopy.

Authors:  L Benkoel; F Chanussot; F Dodero; C De la Maisonneuve; P Bongrand; A M Benoliel; R Lambert; J Brisse; A Chamlian
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

4.  Effect of dietary lipids on hepatic Na+,K(+)-ATPase in cyclosporine A-treated rats: immunocytochemical analysis of alpha1 subunit by confocal laser scanning microscopy imaging.

Authors:  L Benkoël; F Chanussot; F Dodero; C de la Maisonneuve; R Lambert; J Brisse; A Chamlian
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

5.  Effect of cyclosporin A and its vehicle on cardiac and skeletal muscle mitochondria: relationship to efficacy of the respiratory chain.

Authors:  H Sanchez; J Zoll; X Bigard; V Veksler; B Mettauer; E Lampert; J Lonsdorfer; R Ventura-Clapier
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

6.  Effect of cyclosporine on colchicine partitioning in the rat liver.

Authors:  K V Speeg; A L Maldonado
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.

Authors:  Y K Oh; D E Nix; R M Straubinger
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats.

Authors:  M J Lee; R M Straubinger; W J Jusko
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.